Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£154.75	257.89%	£250,520.34
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£154.75	235.46%	£234,825.49
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,596.00	13.07%	£79,151.70
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,596.00	230.32%	£231,224.49
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£13,596.00	250.73%	£245,510.13
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,596.00	83.19%	£128,229.59
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,596.00	15.47%	£80,832.34
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,596.00	409.88%	£356,917.31
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,596.00	11.85%	£78,292.20
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,596.00	150.99%	£175,691.34
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,596.00	14.02%	£79,815.50
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,596.00	32.90%	£93,032.26
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,596.00	69.84%	£118,890.69
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,596.00	362.76%	£323,934.65
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.66	-49.85%	£35,105.74
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£48.88	30.73%	£91,511.10
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£48.88	-8.52%	£64,038.93
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£48.88	14.26%	£79,981.30
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£48.88	24.12%	£86,886.74
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£48.88	15.53%	£80,869.77
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£48.88	23.78%	£86,644.72
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£48.88	9.23%	£76,460.34
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£48.88	11.04%	£77,728.31
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£48.88	30.80%	£91,560.08
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£210.01	27.26%	£89,078.95
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£210.01	71.24%	£119,868.72
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£210.01	188.91%	£202,238.26
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£210.01	244.67%	£241,271.95
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£210.01	29.86%	£90,902.17
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£232.37	222.05%	£225,432.29
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£232.37	-6.63%	£65,355.61
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£336.73	32.98%	£93,085.46
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£336.73	-31.29%	£48,098.40
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£336.73	-37.39%	£43,826.30
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£336.73	-35.02%	£45,486.49
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£336.73	-43.35%	£39,655.28
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£336.73	-6.76%	£65,266.79
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,421.58	111.39%	£147,973.35
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£578.90	38.45%	£96,912.52
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£578.90	26.06%	£88,239.27
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£578.90	-0.81%	£69,431.50
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£578.90	25.02%	£87,515.12
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£578.90	21.26%	£84,880.92
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£130.70	-78.66%	£14,934.70
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£130.70	-59.16%	£28,590.62
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£50.29	38.35%	£96,844.57
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£50.29	-50.55%	£34,617.96
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£50.29	-59.03%	£28,678.62
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£50.29	-62.65%	£26,142.14
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£117.66	-30.01%	£48,995.84
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£117.66	-27.74%	£50,584.69
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£132.36	49.76%	£104,833.68
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£132.36	100.40%	£140,278.98
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£132.36	144.92%	£171,446.91
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£169.20	-25.63%	£52,061.54
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£317.90	26.23%	£88,358.15
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£317.90	2.66%	£71,865.01
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£317.90	24.28%	£86,993.74
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£317.90	4.92%	£73,442.24
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£317.90	2.88%	£72,016.18
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£123.28	387.92%	£341,546.28
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£123.28	13.29%	£79,301.60
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£123.28	274.71%	£262,297.85
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£18.40	-81.82%	£12,727.27
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£25.80	32.01%	£92,404.08
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£25.80	-11.10%	£62,227.00
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£32.79	45.06%	£101,539.30
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£32.79	56.29%	£109,402.15
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£392.21	350.35%	£315,245.16
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£352.97	408.46%	£355,919.05
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£352.97	28.35%	£89,846.91
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.15	-5.54%	£66,119.25
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.15	-17.83%	£57,515.92
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£8.02	-37.39%	£43,825.14
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£99.75	-1.01%	£69,291.46
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£80.83	1.75%	£71,224.82
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£36.33	-61.86%	£26,696.41
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£163.87	-40.14%	£41,902.83
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£223.98	39.28%	£97,497.67
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£547.36	97.00%	£137,898.86
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£547.36	56.04%	£109,225.46
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£547.36	-0.71%	£69,499.73
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£4.42	27.01%	£88,908.05
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£482.35	1,454.96%	£1,088,475.19
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£22.00	-12.04%	£61,574.87
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,560.00	-4.41%	£66,915.61
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£707.50	2,261.48%	£1,653,037.44
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,009.38	38.02%	£96,613.84
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,528.00	-24.58%	£52,793.68
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.30	-94.69%	£3,719.10
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£874.60	57.02%	£109,913.82
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£6.47	362.14%	£323,499.99
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.07	-56.94%	£30,140.25
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.94	53.13%	£107,187.50
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.22	17.31%	£82,115.39
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£32.00	112.62%	£148,837.21
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.05	-96.70%	£2,309.52
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.65	-94.58%	£3,793.42
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£7.79	-26.65%	£51,346.52
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.75	-40.00%	£42,000.00
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£38.81	29.02%	£90,315.83
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£29.63	-73.54%	£18,522.06
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£361.60	7.59%	£75,310.92
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.20	-50.99%	£34,308.30
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£284.90	37.30%	£96,110.84
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£284.90	4.28%	£72,997.80
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.85	-96.73%	£2,288.46
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£77.00	-31.25%	£48,125.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£77.00	49.51%	£104,660.19
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£72.69	316.08%	£291,259.33
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£4.18	-86.07%	£9,753.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.59	-9.11%	£63,620.25

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.